News
ATR
161.30
+1.31%
2.08
AptarGroup declares $0.45 dividend
Seeking Alpha · 11h ago
AptarGroup Board Approves $500M Stock Buyback
Dow Jones · 1d ago
Aptar authorizes $500M share repurchase
Seeking Alpha · 1d ago
AptarGroup authorizes share repurchase of up to $500M, declares 45c dividend
TipRanks · 1d ago
*Aptar: Announces New $500M Shr Repurchase Authorization >ATR
Dow Jones · 1d ago
AptarGroup Plans Repurchase Of Up To $500M Of Common Stock
Benzinga · 1d ago
Weekly Report: what happened at ATR last week (0930-1004)?
Weekly Report · 4d ago
Here's Why You Should Retain Berry Global Stock in Your Portfolio
NASDAQ · 10/01 14:29
Is AptarGroup, Inc.'s (NYSE:ATR) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Simply Wall St · 09/30 18:26
Weekly Report: what happened at ATR last week (0923-0927)?
Weekly Report · 09/30 09:04
AptarGroup: Hold Rating Justified by Solid Pharma Performance Amidst Growth and Margin Challenges
TipRanks · 09/26 07:03
AptarGroup Says N-Sorb Nitrosamine Mitigation Solution Has Been Accepted Into FDA Emerging Technology Program
Benzinga · 09/23 21:01
Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
Barchart · 09/23 16:00
Weekly Report: what happened at ATR last week (0916-0920)?
Weekly Report · 09/23 09:04
Return Trends At AptarGroup (NYSE:ATR) Aren't Appealing
Simply Wall St · 09/17 10:23
Weekly Report: what happened at ATR last week (0909-0913)?
Weekly Report · 09/16 09:04
How Is The Market Feeling About AptarGroup?
Benzinga · 09/13 19:00
Weekly Report: what happened at ATR last week (0902-0906)?
Weekly Report · 09/09 09:04
Weekly Report: what happened at ATR last week (0826-0830)?
Weekly Report · 09/02 09:04
AptarGroup (NYSE:ATR) shareholders have earned a 6.2% CAGR over the last five years
Simply Wall St · 08/31 14:15
More
Webull provides a variety of real-time ATR stock news. You can receive the latest news about Aptargroup through multiple platforms. This information may help you make smarter investment decisions.
About ATR
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.